Pleriksafor Teva 20 mg/ml otopina za injekciju
Name | Pleriksafor Teva 20 mg/ml otopina za injekciju |
---|---|
Marketing Authorisation Number | HR-H-485257144 |
Active Substance | pleriksafor |
Composition | 1 ml otopine za injekciju sadrži 20 mg pleriksafora jedna bočica sadrži 24 mg pleriksafora u 1,2 ml otopine |
Pharmaceutical Form | otopina za injekciju |
Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
Marketing Authorisation Holder | TEVA GmbH, Graf-Arco-Str. 3, Ulm, Njemačka |
Marketing Authorisation Date | 29.03.2023 |
MA Period of Validity | 29.03.2028 |
Classification Number | UP/I-530-09/21-01/230 |
Registration Number | 381-12-01/171-23-06 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L03AX16 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |